MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-17-0004576
Ashish Life Science Private Limited - pharma in Palghar, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹214.76 Cr
▲ 15% YoY
Net profit · FY 2025
₹9.28 Cr
Net margin 4.3%
EBITDA · FY 2025
₹26.95 Cr
EBITDA margin 12.5%
Authorised capital
₹5.36 Cr
Registered with MCA
Paid-up capital
₹4.8 Cr
Issued & subscribed
Open charges
₹101.48 Cr
Satisfied ₹53.94 Cr
Company age
34 yrs
Est. 1992
Employees · EPFO
246
Provident fund records
About Ashish Life Science Private Limited
Data last updated:
Ashish Life Science Private Limited is a private limited company based in Palghar, Maharashtra, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 10 January 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH1992PTC064810. Its GSTIN is 27AABCB4093N1ZC (Maharashtra).
The company has an authorised share capital of ₹5.36 Cr and a paid-up capital of ₹4.8 Cr. It was formerly known as Bhagat Chem India Pvt Ltd. It is led by directors including Raujesh Premsukh Agarrwal (Managing Director) and Parimal Merchant.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot J – 137 MIDC Tarapur, Palghar, Maharashtra, India – 401506.
As per the financials filed for FY 2025, the company reported a revenue of ₹214.76 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹9.28 Cr (net margin 4.3%) and EBITDA of ₹26.95 Cr (EBITDA margin 12.5%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 17% over five years.
The company has about 246 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Ashish Life Science. As per MCA filings, the company has open charges of ₹101.48 Cr and satisfied charges of ₹53.94 Cr on record. Court records list 27 cases involving the company, including 13 filed by the company and 14 filed against it; 5 cases are pending. The company has 10 deals on record (6 secondary share transfers, 4 funding rounds), with disclosed funding of ₹42.85 Cr; the latest was in February 2019. Its 6 peer companies in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Biovet Private Limited with revenue of ₹248.76 Cr. The company has 11 MSME Form 1 returns on record between 2021 and 2023, listing 1,957 overdue payments to 102 micro and small suppliers.
Ashish Life Science Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0004576). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ashishlifescience.com.
Company details
CIN U24100MH1992PTC064810
Registration Number 064810
Incorporation Date 10 January 1992
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-17-0004576
Key People
Raujesh Premsukh Agarrwal Managing Director Parimal Merchant Director Rajkumar Harnathrai Agarwal Director Recognitions & Rankings of Ashish Life Science
Contact details
Ashish Life Science Private Limited's registered office is in Palghar, Maharashtra. Its website is ashishlifescience.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot J – 137 MIDC Tarapur, Palghar, Maharashtra, India – 401506
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Ashish Life Science Private Limited, buy the company report.
Comprehensive company report
Ashish Life Science Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Ashish Life Science operates one associated brand: Ashish Life Science. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Veterinary products are manufactured in Mumbai, India. | ashishlifescience.com |
Business activity
The main business activity of Ashish Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ashish Life Science Private Limited, buy the company report.
Financials of Ashish Life Science Private Limited
FY 2024 filings availableAshish Life Science Private Limited reported revenue of ₹214.76 Cr (up 15% YoY) for FY 2025.
Revenue · FY 2025
₹214.76 Cr ▲ 15%
Net profit · FY 2025
₹9.28 Cr margin 4.3%
EBITDA · FY 2025
₹26.95 Cr margin 12.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 11%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 9%
5 years · compounded
▲ 35%
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 15% growth in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26.95 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.28 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.5% | ||||
| Net Profit Margin | 4.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ashish Life Science Private Limited, buy the company report.
Board of directors and KMP of Ashish Life Science Private Limited
Ashish Life Science Private Limited currently reports 4 directors and 1 key managerial person. 8 former directors have served the organization.
Current Directors and KMP
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parimal Merchant Also directs: Orion Legacy Sucess Partners LLP, Hind Rectifiers Limited, Sunjewels Private Limited and 1 more | Director | 12 Aug 2019 | 7 Years 2 Months | Current |
| Rajkumar Harnathrai Agarwal Also directs: Jai Hanuman Dyeing and Printing Mills Pvt Ltd | Director | 29 Jul 2013 | 13 Years 3 Months | Current |
| Bhavik Bhupendra Parekh | Company Secretary | 01 May 2022 | 4 Years 5 Months | Current |
| Raujesh Premsukh Agarrwal | Managing Director | 18 Jun 2005 | 21 Years 4 Months | Current |
| Chintan Natwar Kothari | Director | 24 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Ashish Life Science Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biovet Private Limited | ₹248.76 Cr (FY 2025) | -10.0% | Malur, Karnataka, India | |||
| Neospark Drugs and Chemicals Private Limited. | ₹228.21 Cr (FY 2025) | 17.0% | Telangana, India | |||
| Salvi Chemical Industries Limited | ₹225.29 Cr (FY 2025) | 47.0% | Mumbai, Maharashtra, India | |||
| Concept Pharmaceuticals Limited | ₹222.11 Cr (FY 2024) | -29.0% | Mumbai, Maharashtra, India | |||
| Ashish Life Science Private Limitedthis company | ₹214.76 Cr (FY 2025) | ₹9.28 Cr | 4.3% | 15.0% | 246 | Palghar, Maharashtra, India |
| Unique Biotech Limited | ₹198.58 Cr (FY 2024) | 16.0% | Hyderabad, Telangana, India | |||
| Brilliant Bio Pharma Private Limited | ₹174.32 Cr (FY 2025) | 85.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Ashish Life Science Private Limited, buy the company report.
Auditor
Ashish Life Science Private Limited is audited by S R B C & CO LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R B C & CO LLP | FY 2024 | 324982E/E300003 |
Shareholding
The shareholding of Ashish Life Science Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ashish Life Science Private Limited, buy the company report.
Charges & borrowings
Open charges
₹101.48 Cr
Satisfied charges
₹53.94 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Jul 2025 | 101139333 | Others | ₹3.64 Cr | Open | |
| 27 Mar 2025 | 101095143 | Hdfc Bank Limited | ₹4 Cr | Open | |
| 03 Jan 2025 | 101037085 | Sidbi | ₹3 Cr | Open | |
| 08 Nov 2023 | 100822259 | Sidbi | ₹8.33 Cr | Open | |
| 07 Feb 2022 | 100535786 | Others | ₹7 Cr | Open |
To see the full charge records of Ashish Life Science Private Limited, buy the company report.
Total charge records: 21 View all charges
Deals & funding
Ashish Life Science Private Limited has 10 deals on record (6 secondary share transfers, 4 funding rounds), with disclosed funding of ₹42.85 Cr; the latest was in February 2019.
Total deals
10
Secondary share transfers
6
Funding rounds
4
Disclosed funding
₹42.85 Cr
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2019 | Secondary share transfer | Undisclosed | Buyer: Eight Roads Ventures, Anterra Capital Seller: an individual |
| Jul 2013 | Secondary share transfer | Undisclosed | Seller: Ashish Interchem Private Limited |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Siddharth Banka, Pawan Kumar Banka (HUF), Hanuman Prasad Banka (HUF), an individual |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: Ashish Interchem Private Limited , Hanuman Prasad Banka Seller: Hanuman Prasad Banka (HUF), Banka Textiles Pvt Ltd |
| Mar 2006 | Funding round | ₹25.8 Lakh | Investors: Ashish Interchem Private Limited , Premsukh Agarwal (HUF), 2 individuals |
To see the full deal history of Ashish Life Science Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ashish Life Science Private Limited has 27 court cases on record: 13 filed by Ashish Life Science, 14 filed against it. 5 cases are pending and 22 are disposed.
Total cases
27
Filed by the company
13
Filed against the company
14
Pending
5
Disposed
22
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 19 | 11 | 1 |
| High courts | 7 | 2 | 4 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 27)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (2406-Indirect Taxation : Goods and Services Tax, Integrated Goods and Services Tax, State Goods and Services Tax, UT Goods and Services Tax.) | Filed against the company by Union of India and 97 others | Disposed |
| Bombay High Court | Writ petition | Filed against the company by M/S Sava Medica Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (T.Cri.M.A.) | Filed against the company by Sava Medica Limited and Anr. | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Criminal miscellaneous application | Filed against the company by Sava Medica Limited and Anr. and 1 other | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Cri.Rev.App.) | Filed against the company by Sava Medica Limited and Anr. and 1 other | Disposed |
To see the full case history of Ashish Life Science Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Ashish Life Science Private Limited was last rated by Crisil on 09 Nov 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 09 Nov 2021 |
To see the full credit ratings and regulatory alerts of Ashish Life Science Private Limited, buy the company report.
MSME payment delays
Ashish Life Science Private Limited has 11 MSME Form 1 returns on record between 2021 and 2023, listing 1,957 overdue payments to 102 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 102)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Simson Pharma Limited | |||
| an individual supplier | |||
| BSB Pharma Analytic Private Limited | |||
| Vajrachem India Limited | |||
| Advanced Microdevices Private Limited |
To see the full MSME payment records of Ashish Life Science Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Ashish Life Science Private Limited has a workforce of 246 employees on its EPFO records as of Feb 18, 2025, across 1 active EPFO establishment.
Employee count
246
Active EPFO establishments
1
Employee growth
19.42%
GST
Ashish Life Science has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCB4093N1ZC | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ashish Life Science Private Limited, buy the company report.
Recent activity
Ashish Life Science Private Limited has 12 board changes on record since 2005: 5 appointments and 7 cessations. The latest: Chintan Natwar Kothari ceased to be Additional Director on 30 Mar 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 25.00 Cr registered on 29 Apr 2015 with Charge ID 10577317 was modified on 22 Sep 2025.
Charges
A charge with Others amounted to Rs. 3.64 Cr with Charge ID 101139333 was registered on 19 Jul 2025.
Charges
A charge with Others of Rs. 23.00 Cr registered on 27 Aug 2021 with Charge ID 100504370 was modified on 19 Jul 2025.
Charges
A charge registered on 20 Sep 2021 via Charge ID 100493461 with Hdfc Bank Limited was fully satisfied on 05 May 2025.
Charges
A charge registered on 19 Jan 2022 via Charge ID 100525182 with Sidbi was fully satisfied on 03 Apr 2025.
Charges
A charge registered on 05 Feb 2021 via Charge ID 100412064 with Sidbi was fully satisfied on 03 Apr 2025.
Ceased
Chintan Natwar Kothari ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.00 Cr with Charge ID 101095143 was registered on 27 Mar 2025.
Appointed
Chintan Natwar Kothari was appointed as Director.
Ceased
Prem Venkatachalam Pavoor ceased to be Director.
Charges
A charge with Sidbi amounted to Rs. 3.00 Cr with Charge ID 101037085 was registered on 03 Jan 2025.
Charges
A charge registered on 14 Oct 2020 via Charge ID 100381804 with Hdfc Bank Limited was fully satisfied on 22 Nov 2024.
49 earlier events are in the company report.
Frequently asked questions
Ashish Life Science is an active private limited company based in Palghar, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 10 January 1992 (34+ years old) and is registered under CIN U24100MH1992PTC064810.
Ashish Life Science has 5 current directors and KMP:
- Raujesh Premsukh Agarrwal - Managing Director
- Parimal Merchant - Director
- Rajkumar Harnathrai Agarwal - Director
- Chintan Natwar Kothari - Director
- Bhavik Bhupendra Parekh - Company Secretary
The latest financial statements of Ashish Life Science on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Ashish Life Science is 27AABCB4093N1ZC, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ashish Life Science is U24100MH1992PTC064810. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ashish Life Science has 27 court cases on record: 13 filed by the company and 14 filed against it. 5 are pending. Most are in the district courts.
Ashish Life Science was incorporated on 10 January 1992, making it 34+ years old. It is registered with the Registrar of Companies, Mumbai.
Ashish Life Science has 10 deals on record (6 secondary share transfers, 4 funding rounds), with disclosed funding of ₹42.85 Cr; the latest was in February 2019.
The peers of Ashish Life Science by revenue are Biovet Private Limited, Neospark Drugs and Chemicals Private Limited, Salvi Chemical Industries Limited, Concept Pharmaceuticals Limited, Unique Biotech Limited and 1 more, all in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chintan Natwar Kothari ceased to be Additional Director on 30 Mar 2025. Chintan Natwar Kothari was appointed as Director on 24 Mar 2025. Prem Venkatachalam Pavoor ceased to be Director on 05 Mar 2025. Ashish Life Science has 12 board changes on record in total.
Yes, Ashish Life Science is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-17-0004576).
Ashish Life Science has 11 MSME Form 1 returns on record between 2021 and 2023, listing 1,957 overdue payments to 102 micro and small suppliers. The latest return was filed on 08 Jan 2024.